147 related articles for article (PubMed ID: 12271881)
41. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
McManus P; Primrose JG; Henry DA; Birkett DJ; Lindner J; Day RO
Med J Aust; 1996 May; 164(10):589-92. PubMed ID: 8637461
[TBL] [Abstract][Full Text] [Related]
42. The cost effectiveness of misoprostol prophylaxis alongside long-term nonsteroidal anti-inflammatory drugs. Implications of the MUCOSA trial.
Davey PJ; Meyer E
Pharmacoeconomics; 2000 Mar; 17(3):295-304. PubMed ID: 10947304
[TBL] [Abstract][Full Text] [Related]
43. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
Laine L
Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
[TBL] [Abstract][Full Text] [Related]
44. Use of misoprostol in the elderly: is the expense justified?
Stucki G; Johannesson M; Liang MH
Drugs Aging; 1996 Feb; 8(2):84-8. PubMed ID: 8845589
[TBL] [Abstract][Full Text] [Related]
45. Double-blind comparison of the efficacy of diclofenac/misoprostol and diclofenac in the treatment of rheumatoid arthritis.
de Queiroz MV; Beaulieu A; Kruger K; Woods E; Stead H; Geis S
Eur J Rheumatol Inflamm; 1994; 14(2):5-13. PubMed ID: 7744133
[TBL] [Abstract][Full Text] [Related]
46. Adverse gastrointestinal effects of NSAIDs: consequences and costs.
Bidaut-Russell M; Gabriel SE
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):739-53. PubMed ID: 11566038
[TBL] [Abstract][Full Text] [Related]
47. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
Pavelka K; Recker DP; Verburg KM
Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
[TBL] [Abstract][Full Text] [Related]
48. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
[TBL] [Abstract][Full Text] [Related]
49. Inadequate prevention of NSAID-induced gastrointestinal events.
Herings RM; Goettsch WG
Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
[TBL] [Abstract][Full Text] [Related]
50. [Arthrotec treatment of rheumatoid arthritis].
Iakushin SS; Filonenko SP; Dediunina RS; Lukina IM
Ter Arkh; 2000; 72(1):59-60. PubMed ID: 10687210
[TBL] [Abstract][Full Text] [Related]
51. [Critical evaluation of economic analysis exemplified by preventive misoprostol administration in antirheumatic drug-induced gastropathy].
Stucki G; Sangha O
Z Rheumatol; 1994; 53(1):37-45. PubMed ID: 8165876
[TBL] [Abstract][Full Text] [Related]
52. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.
Barradell LB; Whittington R; Benfield P
Pharmacoeconomics; 1993 Feb; 3(2):140-71. PubMed ID: 10146962
[TBL] [Abstract][Full Text] [Related]
53. Formulary management of antiulcer drugs: economic considerations.
Tucker PP; Nash DB
Pharmacoeconomics; 1994 Apr; 5(4):313-34. PubMed ID: 10147240
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and gastroduodenal safety of a fixed combination of diclofenac and misoprostol in the treatment of arthritis.
McKenna F
Br J Rheumatol; 1995 Apr; 34 Suppl 1():11-8. PubMed ID: 7780674
[TBL] [Abstract][Full Text] [Related]
55. Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice.
Silverstein FE
Dig Dis Sci; 1998 Mar; 43(3):447-58. PubMed ID: 9539636
[TBL] [Abstract][Full Text] [Related]
56. A decision analysis model in the evaluation of NSAIDs in a managed care setting: a case study.
Brixner DI
Med Interface; 1994 Nov; 7(11):145-50. PubMed ID: 10138701
[TBL] [Abstract][Full Text] [Related]
57. Prevention of gastroduodenal injury induced by NSAIDs with low-dose misoprostol.
Medina Santillán R; Reyes García G; Mateos García E
Proc West Pharmacol Soc; 1999; 42():33-4. PubMed ID: 10697681
[No Abstract] [Full Text] [Related]
58. Misoprostol for co-prescription with NSAIDs.
Drug Ther Bull; 1990 Apr; 28(7):25-6. PubMed ID: 2131244
[No Abstract] [Full Text] [Related]
59. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.
MacDonald TM; Morant SV; Robinson GC; Shield MJ; McGilchrist MM; Murray FE; McDevitt DG
BMJ; 1997 Nov; 315(7119):1333-7. PubMed ID: 9402773
[TBL] [Abstract][Full Text] [Related]
60. Arthrotec, diclofenac and ibuprofen in general practice.
Kiff PS; Stead H; Morant SV; Shield MJ
Eur J Rheumatol Inflamm; 1994; 14(3 Suppl):31-8. PubMed ID: 7556344
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
